Medicines Co. (MDCO) Posts Q4 adj.-EPS of 20c

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of $0.20, $1.02 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $191 million versus the consensus estimate of $189.8 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c